Article
Documented clinical genetic testing among carriers of hereditary breast and ovarian cancer variants: Ancestry and socioeconomic disparities in the All of Us research program
2026-06-10
Abstract excerpt
<h4>Importance</h4> Hereditary breast and ovarian cancer (HBOC) variant carriers benefit from risk-reducing interventions, but only if identified. The extent to which carriers are clinically recognized, and whether recognition is equitable across diverse populations, is poorly characterized in a single large U.S. cohort. <h4>Objective</h4> To estimate P/LP HBOC carrier prevalence across genetic ancestry groups,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d247986-7fa3-59e7-b675-cbacfda351ba
- DOI
- 10.64898/2026.06.09.26355262
